ARCHIVE

• Strict Safety Measures Required for GE Pravastatin, Simvastatin
  April 7, 2003

• BULLETIN
  April 7, 2003

• METI Stresses Need for Protection of NDA Data
  April 7, 2003

• Yamanouchi Global Strategy Focusing on Urology: President Takenaka
  April 7, 2003

• New ADRs of Allopurinol, Hydroxycarbamide Reported
  April 7, 2003

• Nidek, Otsuka to Comarket Toyama's New Quinolone Eye Drop
  April 7, 2003

• 10 Advanced Medical Technologies Approved
  April 7, 2003

• Ushioda Sangokudo Acquires Kuraya Sanseido's North Kanto Business
  April 7, 2003

• Test Conditions Announced for 24th Quality Reevaluation
  April 7, 2003

• BUSINESS NEWS IN BRIEF
  April 7, 2003

• REGULATORY NEWS IN BRIEF
  April 7, 2003

• Social Sec. Premiums to Account for 13.5% of Household Costs in 2025
  April 7, 2003

• WEBSITE NEWS
  April 7, 2003

• Gov't Draft Plan Recommends Regulatory Reform in Nursing Care Field
  April 7, 2003

• Predicting Disease Prevalence to Be Major Issue: JPMA Seminar
  March 31, 2003

• GL for Treatment of H. pylori Infection Revised
  March 31, 2003

• 1 in 3 GPs Rarely See MRs: Survey
  March 31, 2003

• AstraZeneca to Study Proper Use of Iressa with IMSUT
  March 31, 2003

• MR Activities Over-concentrated in GP market: MOSS Institute Survey
  March 31, 2003

• Promoting Development of Venture Biz Stressed: Regenerative Medicine Seminar
  March 31, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 607
• 608
• 609
• 610
• 611
• 612
• 613
• 614
• 615
• …
• Next ›
• 最終 »